190 related articles for article (PubMed ID: 15163019)
1. Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.
Kren L; Brazdil J; Hermanova M; Goncharuk VN; Kallakury BV; Kaur P; Ross JS
Appl Immunohistochem Mol Morphol; 2004 Mar; 12(1):44-9. PubMed ID: 15163019
[TBL] [Abstract][Full Text] [Related]
2. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
[TBL] [Abstract][Full Text] [Related]
3. Survivin and Bcl-2 expression in prostatic adenocarcinomas.
Kaur P; Kallakury BS; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
Arch Pathol Lab Med; 2004 Jan; 128(1):39-43. PubMed ID: 14692814
[TBL] [Abstract][Full Text] [Related]
4. Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis.
Ulukus EC; Kargi HA; Sis B; Lebe B; Oztop I; Akkoclu A; Onen A; Sanli A
Appl Immunohistochem Mol Morphol; 2007 Mar; 15(1):31-7. PubMed ID: 17536304
[TBL] [Abstract][Full Text] [Related]
5. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
[TBL] [Abstract][Full Text] [Related]
6. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.
Gao Q; Yang S; Kang MQ
Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832
[TBL] [Abstract][Full Text] [Related]
7. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
Bria E; Visca P; Novelli F; Casini B; Diodoro MG; Perrone-Donnorso R; Botti C; Sperduti I; Facciolo F; Milella M; Cecere FL; Cognetti F; Mottolese M
Eur J Surg Oncol; 2008 May; 34(5):593-8. PubMed ID: 17693049
[TBL] [Abstract][Full Text] [Related]
8. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival.
Laudanski J; Chyczewski L; Niklińska WE; Kretowska M; Furman M; Sawicki B; Nikliński J
Neoplasma; 1999; 46(1):25-30. PubMed ID: 10355530
[TBL] [Abstract][Full Text] [Related]
10. [Expression of survivin and its clinical significance in non-small cell lung cancer].
Ren YJ; Zhang QY
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):504-7. PubMed ID: 16224523
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer.
Vischioni B; van der Valk P; Span SW; Kruyt FA; Rodriguez JA; Giaccone G
Ann Oncol; 2004 Nov; 15(11):1654-60. PubMed ID: 15520067
[TBL] [Abstract][Full Text] [Related]
12. Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung.
Eerola AK; Ruokolainen H; Soini Y; Raunio H; Pääkkö P
Pathol Oncol Res; 1999; 5(3):179-86. PubMed ID: 10491014
[TBL] [Abstract][Full Text] [Related]
13. Survivin gene expression in early-stage non-small cell lung cancer.
Falleni M; Pellegrini C; Marchetti A; Oprandi B; Buttitta F; Barassi F; Santambrogio L; Coggi G; Bosari S
J Pathol; 2003 Aug; 200(5):620-6. PubMed ID: 12898598
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers.
Harada T; Ogura S; Yamazaki K; Kinoshita I; Itoh T; Isobe H; Yamashiro K; Dosaka-Akita H; Nishimura M
Cancer Sci; 2003 Apr; 94(4):394-9. PubMed ID: 12824911
[TBL] [Abstract][Full Text] [Related]
15. Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer.
Lai RS; Wang JS; Hsu HK; Chang HC; Lin CH; Lin MH
Jpn J Clin Oncol; 2002 Oct; 32(10):393-7. PubMed ID: 12451034
[TBL] [Abstract][Full Text] [Related]
16. A multiple marker analysis of apoptosis-associated protein expression in non-small cell lung cancer in a Chinese population.
Fan CF; Xu HT; Lin XY; Yu JH; Wang EH
Folia Histochem Cytobiol; 2011; 49(2):231-9. PubMed ID: 21744322
[TBL] [Abstract][Full Text] [Related]
17. Survivin expression in breast carcinoma: correlation with apoptosis and prognosis.
Nassar A; Sexton D; Cotsonis G; Cohen C
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):221-6. PubMed ID: 18301249
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic regulators: P53 and survivin expression in non-small cell lung cancer.
Porebska I; Sobańska E; Kosacka M; Jankowska R
Cancer Genomics Proteomics; 2010; 7(6):331-5. PubMed ID: 21156966
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma.
Krepela E; Dankova P; Moravcikova E; Krepelova A; Prochazka J; Cermak J; Schützner J; Zatloukal P; Benkova K
Int J Oncol; 2009 Dec; 35(6):1449-62. PubMed ID: 19885569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
